Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
RSC Advances|February 6, 2023
Serum metabolomics strategy for investigating the hepatotoxicity induced by different exposure times and doses of Gynura segetum (Lour.) Merr. in rats based on GC-MSYing Li, Yingxin Tian, Qixue Wang, et al.
Heliyon|August 8, 2024
Danggui-Shaoyao-San protects against non-alcoholic steatohepatitis via modulation of hepatic APP protein, Lysosomal CTSB release, and NF-κB activationSiting Gao, Ziming An, Qian Zhang, et al.
Frontiers in Microbiology|August 26, 2022
Investigation of Gynura segetum root extract (GSrE) induced hepatotoxicity based on metabolomic signatures and microbial community profiling in ratsXinyi Gu, Shuwei Li, Mengna Lu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 28, 2013
Differences of excess and deficiency zheng in patients with chronic hepatitis B by urinary metabonomicsShujun Sun, Jianye Dai, Junwei Fang, et al.
Pathogens and Disease|July 27, 2019
Phenotypic and genetic characterization of Pseudomonas aeruginosa isolate COP2 from the lungs of COPD patients in ChinaKelei Zhao, Yang Yuan, Jing Li, et al.
BMC Gastroenterology|May 5, 2025
Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver diseaseSheng Lyu, Jiani Yang, Xin Xin, et al.
Oncotarget|October 26, 2016
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significanceMajed Saad Al Fayi, Xiaojun Gou, Shiva S Forootan, et al.
International Journal of Molecular Sciences|July 11, 2018
PD-L1 Nanobody Competitively Inhibits the Formation of the PD-1/PD-L1 Complex: Comparative Molecular Dynamics SimulationsXin Sun, Xiao Yan, Wei Zhuo, et al.
Oncotarget|August 22, 2020
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Waseem Al-Jameel, Xiaojun Gou, Shiva S Forootan, et al.
Genes & Cancer|July 2, 2019
Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγWaseem Al-Jameel, Xiaojun Gou, Xi Jin, et al.
Pageof 5